170 related articles for article (PubMed ID: 11361052)
1. Linezolid, a novel oxazolidinone antibiotic: assessment of monoamine oxidase inhibition using pressor response to oral tyramine.
Antal EJ; Hendershot PE; Batts DH; Sheu WP; Hopkins NK; Donaldson KM
J Clin Pharmacol; 2001 May; 41(5):552-62. PubMed ID: 11361052
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral linezolid on the pressor response to intravenous tyramine.
Cantarini MV; Painter CJ; Gilmore EM; Bolger C; Watkins CL; Hughes AM
Br J Clin Pharmacol; 2004 Nov; 58(5):470-5. PubMed ID: 15521893
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular sympathomimetic amine interactions in rats treated with monoamine oxidase inhibitors and the novel oxazolidinone antibiotic linezolid.
Humphrey SJ; Curry JT; Turman CN; Stryd RP
J Cardiovasc Pharmacol; 2001 May; 37(5):548-63. PubMed ID: 11336106
[TBL] [Abstract][Full Text] [Related]
4. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
Cusson JR; Goldenberg E; Larochelle P
J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
[TBL] [Abstract][Full Text] [Related]
5. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
Dingemanse J; Hussain Y; Korn A
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
[TBL] [Abstract][Full Text] [Related]
6. Influence of food on the tyramine pressor effect during chronic moclobemide treatment of healthy volunteers.
Audebert C; Blin O; Monjanel-Mouterde S; Auquier P; Pedarriosse AM; Dingemanse J; Durand A; Cano JP
Eur J Clin Pharmacol; 1992; 43(5):507-12. PubMed ID: 1483487
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
Simpson GM; Gratz SS
Clin Pharmacol Ther; 1992 Sep; 52(3):286-91. PubMed ID: 1526086
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects.
Dingemanse J; Wood N; Guentert T; Oie S; Ouwerkerk M; Amrein R
Psychopharmacology (Berl); 1998 Nov; 140(2):164-72. PubMed ID: 9860107
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive action and weak potentiation of tyramine effect by moclobemide in rats.
Da Prada M; Burkard WP
Acta Psychiatr Scand Suppl; 1990; 360():106-7. PubMed ID: 2248060
[TBL] [Abstract][Full Text] [Related]
10. In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
Flanagan S; Bartizal K; Minassian SL; Fang E; Prokocimer P
Antimicrob Agents Chemother; 2013 Jul; 57(7):3060-6. PubMed ID: 23612197
[TBL] [Abstract][Full Text] [Related]
11. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
[TBL] [Abstract][Full Text] [Related]
12. Interaction between moclobemide and oral tyramine in depressed patients.
Burgess CD; Mellsop GW
Fundam Clin Pharmacol; 1989; 3(1):47-52. PubMed ID: 2714732
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
[TBL] [Abstract][Full Text] [Related]
14. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the pressor effect of oral and intravenous tyramine during administration of the selective MAO-A inhibitor moclobemide in healthy volunteers.
Wijnands S; Chang PC; Blauw GJ; van den Krogt J; Gieschke R; Schoerlin MP; van Brummelen P
J Psychopharmacol; 1989 Jan; 3(1):36-44. PubMed ID: 22156310
[TBL] [Abstract][Full Text] [Related]
16. Interaction of moclobemide and tricyclic antidepressants with the tyramine pressor effect in rats.
Burkard W; d'Agostini F; Kettler R; Da Prada M
Psychopharmacology (Berl); 1992; 106 Suppl():S35-6. PubMed ID: 1546137
[TBL] [Abstract][Full Text] [Related]
17. Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.
Barrett JS; Hochadel TJ; Morales RJ; Rohatagi S; DeWitt KE; Watson SK; Darnow J; Azzaro AJ; DiSanto AR
J Clin Pharmacol; 1997 Mar; 37(3):238-47. PubMed ID: 9089426
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects.
Provost JC; Funck-Brentano C; Rovei V; D'Estanque J; Ego D; Jaillon P
Clin Pharmacol Ther; 1992 Oct; 52(4):384-93. PubMed ID: 1424410
[TBL] [Abstract][Full Text] [Related]
19. Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.
Korn A; Wagner B; Moritz E; Dingemanse J
Eur J Clin Pharmacol; 1996; 49(4):273-8. PubMed ID: 8857072
[TBL] [Abstract][Full Text] [Related]
20. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
Korn A; Da Prada M; Raffesberg W; Allen S; Gasic S
J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
